C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2001
11/14/2001	CN1321662A Novel polypeptide-human pax protein 11.7 and polynucleotide for coding this polypeptide
11/14/2001	CN1321661A Novel polypeptide-human K-ras proto-oncogene protein 36 and polynucleotide for coding this polypeptide
11/14/2001	CN1321660A Novel polypeptide-human laminin B2 strand 13 and polynucleotide for coding this polypeptide
11/14/2001	CN1321659A Novel polypeptide-human laminin B2 strand 12 and polynucleotide for coding this polypeptide
11/14/2001	CN1321657A Novel polypeptide-human myb protein 14 and polynucleotide for coding this polypeptide
11/14/2001	CN1321656A Novel polypeptide-human Pax protein 11 and polynucleotide for coding this polypeptide
11/14/2001	CN1321655A Novel polypeptide-human pax protein 10.3 and polynucleotide for coding this polypeptide
11/14/2001	CN1321654A Novel polypeptide-human pax protein 11.4 and polynucleotide for coding this polypeptide
11/14/2001	CN1321653A Novel polypeptide-human kruppel related DNA bindin 10 and polynucleotide for coding this polypeptide
11/14/2001	CN1321651A Novel-polypeptide-human kingle protein 15 and polynucleotide for coding this polypeptide
11/14/2001	CN1321650A Novel polypeptide-cytokine receptor 10 and polynucleotide for coding this polypeptide
11/14/2001	CN1321649A Novel polypeptide-central cannabis receptor 10 and polynucleotide for coding this polypeptide
11/14/2001	CN1321648A Novel polypeptide-central cannabis receptor 9 and polynucleotide for coding this polypeptide
11/14/2001	CN1321647A Novel polypeptide-catenin 10 and polynucleotide for coding this polypeptide
11/14/2001	CN1321646A Novel polypeptide-human inclusion analogous protein 9 and polynucleotide for coding this polypeptide
11/14/2001	CN1321645A Novel polypeptide-KIAA0883-44 polynucleotide for coding this polypeptide
11/14/2001	CN1321640A Method for separating and recovery of protein and isoflavone from plant raw material
11/13/2001	US6316699 Plants with modified stamen cells
11/13/2001	US6316697 Constitutive disease resistance(CDR1) gene and methods of use thereof
11/13/2001	US6316693 Transgenic mouse model for fatty acid transport
11/13/2001	US6316690 Non-mammalian transgenic animal model for cellular proliferative diseases
11/13/2001	US6316611 Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
11/13/2001	US6316609 Nucleotide sequence of Escherichia coli pathogenicity islands
11/13/2001	US6316604 Purification of genetically engineered complement receptor; express complement receptor in cells, obtain sample, subject to chromatography column, elute receptor protein
11/13/2001	US6316603 Modifications of the VEGF receptor-2 protein and methods of use
11/13/2001	US6316602 Therapy of wound by treating with cell growth factor, wherein the cell growth factor consists of peptide
11/13/2001	US6316601 Antibodies specific for β6 integrins
11/13/2001	US6316599 Preferential antibody for use in the diagnosis and detection and treatment of tumors
11/13/2001	US6316597 Protein for use in treatment of bone or cartilage defects
11/13/2001	US6316596 Receptor for peptide hormones involving in energy homeostasis
11/13/2001	US6316595 PNA synthesis using a base-labile amino protecting group
11/13/2001	US6316593 Enhanced metabolic stability and receptor-binding properties; airway mucus secretion and anti-allergic and anti-inflammatory agent
11/13/2001	US6316418 Regulated apoptosis
11/13/2001	US6316416 Uteroglobin therapy for epithelial cell cancer
11/13/2001	US6316414 Somatostatin analogs for the treatment of cancer
11/13/2001	US6316412 Polypeptides for promoting cell attachment
11/13/2001	US6316410 Amino acid sequences of peptide hormones
11/13/2001	US6316409 Modified ligands of calcium-dependent binding proteins
11/13/2001	US6316408 Methods of use for osetoprotegerin binding protein receptors
11/13/2001	US6316407 Polypeptides as antigrowth agents for plants
11/13/2001	US6316403 Deactivation of factor ix for coagulation inhibition and antiischemic agents
11/13/2001	US6316272 Monitoring binding of cancer modulator; mix protein and modulator, incubate, detect binding of modulator
11/13/2001	US6316256 Method for protein transfer
11/13/2001	US6316255 Transduced cultured liver cells; for use in the treatment and prevention of liver disorders
11/13/2001	US6316254 Methods for stimulating erythropoiesis using hematopoietic proteins
11/13/2001	US6316252 Biotherapeutic delivery system
11/13/2001	US6316250 Molecular clones producing recombinant DNA antigens of the hantavirus-associated respiratory distress (HARDS)
11/13/2001	US6316243 Viral nucleotide sequences; for the reduction or prevention of viral infection
11/13/2001	US6316239 HKABY60 kinase family polypeptides
11/13/2001	US6316237 Respiratory nitrate reductase alpha subunit
11/13/2001	US6316232 Microbial preparation of substances from aromatic metabolism/I
11/13/2001	US6316226 For use in treatment of hemophilia a
11/13/2001	US6316225 Proteins involved in the initiation of eukaryotic transcription
11/13/2001	US6316224 Chlorella virus promoters
11/13/2001	US6316222 Binds calcium-signal modulating cyclophilin ligand; use in identifying agents for modulating the calcium induced activation pathway
11/13/2001	US6316221 Functional expression of pheromone binding protein
11/13/2001	US6316220 Found in aspergillii
11/13/2001	US6316219 Compounds
11/13/2001	US6316218 Nucleotide sequences coding antispasmodic agent; for treatment of peptic ulcer and inflammatory bowel diseases
11/13/2001	US6316217 Activin receptor-like kinases, proteins having serine threonine kinase domains and polynucleotides encoding same
11/13/2001	US6316213 Methods for the early diagnosis of ovarian, breast and lung cancer
11/13/2001	US6316211 ThdF
11/13/2001	US6316210 Genetic suppressor elements against human immunodeficiency virus
11/13/2001	US6316208 Methods for determining isolated p27 protein levels and uses thereof
11/13/2001	US6316206 Method for screening comprising cells expressing the CNTF receptor
11/13/2001	US6316204 Methods for detecting fohy030 polypeptide
11/13/2001	US6316203 Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/13/2001	US6316183 Nucleic acid-based methods for the detection of human immunodeficiency virus type 2 (HIV-2)
11/13/2001	US6316005 Borrelia burgdorferi bacterin
11/13/2001	US6316004 To stimulate the growth of animal
11/13/2001	US6316003 Presenting to the cell an extracellular fusion protein consisting of a cargo moiety and a transport moiety and allowing transport moiety-dependent intracellular delivery of the fusion protein
11/13/2001	US6316000 For preventing the development of a parasite in an arthropod;for immunization
11/13/2001	US6315998 Administering anti-cd40 monoclonal antibody or an antigen binding fragment which is being free of significant agonistic activity and binding to a human cd40 antigen located on surface of a human b cell prevents growth or differentiation
11/13/2001	US6315995 Adding to blood inactive recombinant mutein comprising proteolytically inactive mutein of factor ix or ixa to inhibit clot formation, does not interfere with hemostasis when the blood is administered to a patient
11/13/2001	US6315992 Generating cartilage in a mammal using fibroblasts transfected with a vector encoding TGF-β-1
11/13/2001	US6315988 Reacting dihydroxyphenylalanine or tyrosine with an oxidant enzyme in an acidic medium in the presence of a protein and/or peptide
11/13/2001	CA1341319C Modified hepatocytes and uses therefor
11/13/2001	CA1341318C Dna clones of human placental plasminogen activator inhibitor
11/12/2001	CA2345915A1 Gpi-anchored small leucine-rich proteoglycan gene
11/09/2001	CA2305787A1 Cxcr4 antagonist treatment of hematopoietic cells
11/08/2001	WO2001084158A1 Use of the g protein coupled receptor gpr3 to identify appetite control agents
11/08/2001	WO2001084148A2 Pharmacogenomics and identification of drug targets by reconstruction of signal transduction pathways based on sequences of accessible regions
11/08/2001	WO2001083819A2 Methods for designing exogenous regulatory molecules
11/08/2001	WO2001083811A1 Gamma secretase substrates and in vitro assays
11/08/2001	WO2001083809A2 Cell membrane nucleic acid transport channel complex
11/08/2001	WO2001083805A2 Improved e. coli extract for protein synthesis
11/08/2001	WO2001083804A2 A method for improving recombinant protein stability and solubility
11/08/2001	WO2001083797A2 Polynucleotides for use in recombinant adeno-associated virus virion production
11/08/2001	WO2001083794A2 Dna transfection system for the generation of infectious influenza virus
11/08/2001	WO2001083793A2 Targeted modification of chromatin structure
11/08/2001	WO2001083792A2 Enhanced gene expression in plants using transcription factors
11/08/2001	WO2001083791A2 Identification and characterization of a pagoda phenotype (pgd) in plants
11/08/2001	WO2001083787A1 Novel promoters and gene expression method by using the promoters
11/08/2001	WO2001083783A2 In vivo loading of mhc
11/08/2001	WO2001083779A1 A novel polypeptide, a human myb protein 14 and the polynucleotide encoding the polypeptide
11/08/2001	WO2001083778A1 A novel polypeptide, a human pax protein 10.3 and polynucleotide encoding it
11/08/2001	WO2001083776A1 A novel polypeptide, a human growth hormone 11 and the polynucleotide encoding the polypeptide
11/08/2001	WO2001083770A2 Lipolytic enzyme variant
11/08/2001	WO2001083761A1 Laccase mutants
11/08/2001	WO2001083757A1 Tt virus polypeptide, nucleic acid coding for said polypeptide and uses

1 ... 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 ... 2916